Pharma News

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for single-dose EMEND® (fosaprepitant dimeglumine) for injection, Merck’s substance P/neurokinin-1 (NK1) receptor antagonist, in combination with other antiemetic medicines, for the prevention of delayed nausea and vomiting in adults receiving initial and repeat courses of moderately emetogenic chemotherapy (MEC). EMEND has not been studied for the treatment of established nausea and vomiting.

Takeda Pharmaceutical Company Limited  and H. Lundbeck A/S announced that the U.S. Food and Drug Administration’s (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) voted 8 to 2 that the companies presented substantial evidence to support the effectiveness of Brintellix (vortioxetine) for treating certain aspects of cognitive dysfunction in adults with Major Depressive Disorder (MDD). Earlier today, the committee also discussed that cognitive dysfunction in MDD represents an appropriate drug development target.

Boehringer Ingelheim announced that SPIRIVA® RESPIMAT® is now available for the treatment of asthma by prescription in U.S. pharmacies. The U.S. Food and Drug Administration (FDA) approved a once-daily dose of 2.5 µg for the long-term maintenance treatment of asthma in people ages 12 and older.

Targovax has submitted a study protocol to the regulatory authorities in Spain to assess its ONCOS-102 product in combination with chemotherapy in patients with malignant pleural mesothelioma (MPM), a rare type of lung cancer associated with exposure to asbestos.

Meditation eases anxiety, fatigue and pain for women undergoing breast cancer biopsies, new research says.Researchers from the Duke Cancer Institute in Durham, US found that during such period even music is effective, but only to a lesser extent.

Using body mass index (BMI) to gauge health is a wrong practice as it is a deeply flawed measure, reveals a study while adding that BMI should not be the primary goal for maintaining good health.

c in the gut increases the risk of colon cancer the second-largest cause of cancer death in the US by as much as 500 percent, says a new study.

Children with childhood attention deficit hyperactivity disorder (ADHD) the most commonly diagnosed mental disorder of children are at a high risk of developing obesity, a new study has found.

[adsense:336x280:8701650588]

Chronic viral infections like CMV, HSV-2 or toxoplasma can contribute to subtle mental deterioration in apparently healthy older adults, a study has revealed.

Abbott and Alere Inc announced a definitive agreement for Abbott to acquire Alere, significantly advancing Abbott's global diagnostics presence and leadership. Under the terms of the agreement, Abbott will pay $56 per common share at a total expected equity value of $5.8 billion. Once the transaction is completed, Abbott will become the leading diagnostics provider of point of care testing. Abbott's total diagnostics sales will exceed $7 billion after the close.